FREE Account Opening + No Clearing Fees
Loading...

Piramal Pharma Limited Rights Issue (Piramal Pharma Rights Issue 2023) Detail

August 8, 2023 - August 17, 2023
Piramal Pharma Limited Logo

Incorporated in 2020, Piramal Pharma Limited a flagship company of Piramal Group offers pharmaceutical products and services across a domestic and global distribution network.

The company has 15 global manufacturing facilities and a global distribution network in over 100 countries.

Piramal Pharma includes:

  1. Piramal Pharma Solutions (PPS), is an integrated Contract Development and Manufacturing Organization (CDMO). It develops and manufactures solutions through a globally integrated network of facilities across the drug life cycle to innovators and generic companies.
  2. Piramal Critical Care (PCC), is a Complex Hospital Generics business whose product portfolio includes inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable pain and anesthetics, injectable anti-infectives, and other therapies.
  3. India Consumer Healthcare (ICH) business, selling over-the-counter products.

Piramal Pharma Rights Issue 2023 Detail

Issue Open August 8, 2023 - August 17, 2023
Security Name Piramal Pharma Limited
Issue Size (Shares) 129,629,630
Issue Size (Amount) ₹1,050.00 Crores
Issue Price ₹81 per share
Face Value ₹10 per share
Listing At BSE, NSE
Terms of Payment

The full amount of Rs. 81 for rights equity shares has to be paid on application.

Entitlement 5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date

Piramal Pharma Rights Issue 2023 Issue Timetable

Last Date to buy sharesAugust 1, 2023
Record Date August 2, 2023
Credit of Rights Entitlements
Bid/Offer Opens On August 8, 2023
Renunciation of Rights Entitlements August 10, 2023
Bid/Offer Closes On August 17, 2023
Deemed Date of Allotment August 23, 2023
Credit Date August 24, 2023
Listing Date August 28, 2023

Company Financials

Piramal Pharma Rights Issue 2023 Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets10,899.7812,797.0414,522.56
Revenue6,479.016,834.907,306.66
Profit After Tax835.03375.96-186.46
Net Worth5,076.756,069.945,968.45
Reserves and Surplus4,488.625,290.695,181.79
Total Borrowing2,910.194,023.285,504.77
Amount in ₹ Crore

Objects of the Issue:

The company intends to utilize the net proceeds from the issue towards the funding of the following objects:

  1. Repayment or prepayment, in full or in part, of certain borrowings, and
  2. General corporate purposes.

Piramal Pharma Rights Issue 2023 Documents

Piramal Pharma Rights Issue 2023 Rating

57
3.4
Rating:Rated 3.4 stars
Vote Here ...

Piramal Pharma Rights Issue 2023 Reviews

Company Contact Information

Piramal Pharma Limited
Ground Floor, Piramal Ananta,
Agastya Corporate Park, Kamani Junction,
LBS Marg, Kurla, Mumbai 400 070

Phone: +91 22 3802 3000
Email: shareholders.ppl@piramal.com
Website: https://www.piramal.com/

Piramal Pharma Rights Issue 2023 Registrar

  1. Link Intime India Private Ltd
    Phone: +91-22-4918 6270
    Email: ppl.rights@linkintime.co.in
    Website: https://linkintime.co.in/initial_offer/public-issues.html

Piramal Pharma Rights Issue 2023 Lead Manager(s)

Piramal Pharma Rights Issue 2023 FAQs

The Piramal Pharma Rights Issue 2023 opens on August 8, 2023, and closes on August 17, 2023.

Piramal Pharma Rights Issue 2023 Schedule

Last Date for credit of Rights Entitlements
Last Date for renunciation of Rights EntitlementsAugust 10, 2023
Issue Opening DateAugust 8, 2023
Issue Closing DateAugust 17, 2023
Date of Allotment (on or about)August 23, 2023
Date of Credit (on or about)August 24, 2023
Date of Listing (on or about)August 28, 2023

Piramal Pharma Rights Issue 2023 price is set at ₹81 per share per equity share.

The eligible shareholders are being offered 5 Rights Equity Share(s) for every 46 fully paid-up Equity Shares held on Record Date (August 2, 2023).

The record date for the Piramal Pharma Rights Issue 2023 is August 2, 2023.

The issue size of Piramal Pharma Rights Issue 2023 is of 129,629,630 equity shares at ₹81 per share aggregating upto ₹1,050.00 Crores.

The Letter of Offer for Piramal Pharma Rights Issue 2023 can be download here.

You can apply for Piramal Pharma Rights Issue 2023 in two ways:

  1. Net Banking (ASBA)
  2. Registrar's Website (R-WAP Facility)

Steps to apply for Piramal Pharma Rights Issue 2023 using Net Banking (ASBA)

  1. Log in to the net banking account of your bank.
  2. Go to the 'IPO & Rights Issue' section.
  3. Check if the Piramal Pharma Rights Issue 2023 available on the list.
  4. Click the Apply button next to the Piramal Pharma Rights Issue 2023.
  5. Fill and check your information.
  6. Submit the application.

Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.

Steps to apply for Piramal Pharma Rights Issue 2023 using Registrar's website (R-WAP)

  1. Visit registrar's website
  2. Go to the 'Rights Issue' section
  3. Select Piramal Pharma Rights Issue 2023 from the dropdown.
  4. Enter Demat Account Number.
  5. Fill the online application form.
  6. Validate and submit the application.

19 Comments

19. Ronak     Link|September 7, 2023 4:01:28 PM
got the email for allotment but shares haven’t been credited in Demat
18. TShah     Link|September 2, 2023 4:35:37 AM
Same issue as others. I applied for Piramal Pharma RE, got the email for allotment but shares haven’t been credited in my delay account yet.
17. Braj Mohan Yadav     Link|August 31, 2023 3:21:54 PM
Hi I had applied QIP and it successfully allotment amount also debited from my account but still shares are not cradit in my deemed account, can you please confirm when will showing these shares in my account
16. Jayantibhai     Link|August 24, 2023 6:56:47 PM
Yet to receive allotment intimation and accordingly credit of shares to my demat account. Fund debited on 23/08. Fund for application wherein mentioned wrong DPID also debited from the account and no intimation of allotment of shares. What will be position?.
15. Rajan Patadiya     Link|August 23, 2023 12:00:17 PM
Any updates on allotment
14. jignesh Modi     Link|August 22, 2023 11:03:58 AM
Amount debited
13. Sarath     Link|August 16, 2023 3:36:21 PM
I bought Piramal pharma limited shares at 16.20rs per share. Now it is not showing in my portfolio. When checking those shares are suspended? How can I get my money back or shares? Those shares were only visible for 2 days. What happened? Expecting swift response
13.1. Pbdrajkot     Link|August 17, 2023 11:15:44 AM
PLEASE APPLY . AS TODAY IS LAST DAY
WHAT SHARE YOU HAVE BOUGHT FOR RE QTY. SAME QTY WITH SAME DEMAT ACCOUNT APPLY

SO YOU CAN GET SHARE AT RS 81 +(16 RS YOU HAVE ALREADY PAID)

PLEASE NOTE THAT TODAY IS LAST DAY TO APPLY FOR RIGHT ISSUE OF PIRAMAL PHARMA

HOLD IT AS IT IS VERY GOOD STOCK WITH GOOD BRAND. AND IT CAN MOVE TO RS 200/250 WITHIN 6 TO 12 MONTH

THANKS
13.2. NKS     Link|August 21, 2023 10:21:21 PM
RE shares was trading only for 3 days...if you have bought RE you need to apply for Right issue @ Rs..81. If you have not applied the value of the RE has become zero
12. SUNILJAIN     Link|August 19, 2023 12:38:10 PM
PIRAMAL PHARMA SUBSCRIBED 1.27 TIMES
CAN YOU TELL US EXPECTED ALLOTMENT RATIO
12.1. Ashok Gandhi     Link|August 19, 2023 2:27:56 PM
What is subscriptions for retail highnetworth and institutions .only overall subscription of 1.27 times given .
11. Dwarkesh     Link|August 18, 2023 12:42:14 AM
The rights issue of pharmaceuticals giant Piramal Pharma Ltd to raise Rs 1,050 crore was oversubscribed by 1.27 times on Thursday (August 17), the closing day. This is as per CNBC
10. Yari     Link|August 17, 2023 6:56:48 PM
Where do we can check rights issue subscription( Like how much Times it’s subscribed and other details)?
9. Sumit bansal     Link|August 13, 2023 3:00:27 PM
Sir please guide me
By mistake my wife applied 2000 shares
And i have no piramal shares
Fund is blocked
I try cancel this bid but failed
Ab kya hoga
9.1. Investor     Link|August 15, 2023 11:00:18 AM
Do not worry, Fund will get refund.
9.2. RATTAN KUMAR SABHERWAL   I Like It. 1|  Link|August 16, 2023 9:12:36 AM
You have taken correct action. You may get allotment at the rate of Rs. 81.00 Wait till 24 Aug 23
8. Amrit Khanna     Link|August 10, 2023 7:25:29 AM
Where Can I get the Piramal Pharma Rights Issue Subscription Status just like in IPO?
7. Amrit Khanna     Link|August 10, 2023 7:22:57 AM
Where Can I get the Piramal Rights Issue Subscription Status just like in IPO?
6. PAREKH M K     Link|August 8, 2023 9:36:32 AM
HOW TO GET THE APPLICATION NUMBER AS IN ASBA IT IS REQUIRED
6.1. Mukesh Ladia     Link|August 10, 2023 4:40:31 AM
As per your ref no in email received of offer, i.e. your DP ID+your dmat no.
6.2. Mukesh Ladia     Link|August 10, 2023 4:42:57 AM
Which is your ref no in email received by company for offer, i.e. your DP ID+your dmat no
5. Praveen     Link|August 7, 2023 10:57:26 AM
How to apply for rights issue from Upstox?
5.1. Prema pant     Link|August 8, 2023 10:37:50 AM
Rught issue payment on line
4. Anant     Link|August 5, 2023 12:23:54 PM
The issue closing date is 16/08/23 and not 17/08/23.
3. Girish Tiwari     Link|August 1, 2023 9:08:04 AM
Is pledged shares are entitled for right issue?
Please elaborate as such shares are not eligible for buyback
3.1. Scrip     Link|August 2, 2023 12:48:54 AM
In pledging shares r not transferred but only lien is marked on those shares. Hence u will be entitled to apply for the rights issue.
2. D.D     Link|June 23, 2023 8:57:02 AM
Dear all & @admin

Can u please tell me, what if I am holding a future lot untill the record date of any company ?

Price of a stock diluted on record date but what happens to the future lot ? Whether it will also dilute price of future lot also ? And if yes whether lot size will be increased or not ?

Please help me as I am holding bpcl in future and it is going to announce right issue. So that i can decide whether to hold or square off.
1. Pbdrajkot     Link|April 12, 2023 3:46:26 PM
Any news for price and date ?

Compare rights issues with Piramal Pharma Rights Issue 2023